8-K: Aclarion Inc. Secures $13.3 Million in Public Offering, Issues Warrants

Aclarion Inc. has successfully completed a public offering, raising approximately $13.3 million and issuing multiple series of warrants.

Summary

• Aclarion Inc. has entered into an underwriting agreement with Dawson James Securities, Inc. for a public offering.
• The offering includes 100,000 shares of common stock, 143.9 million pre-funded warrants, 144 million Series A common warrants, and 144 million Series B common warrants.
• Each share or pre-funded warrant was sold with one Series A and one Series B common warrant.
• The public offering price was $0.10 per share and $0.09999 per pre-funded warrant.
• The underwriter has an option to purchase an additional 21 million shares or pre-funded warrants, and 21 million of each series of warrants.
• The underwriter exercised its option to purchase 21 million Series A and 21 million Series B warrants.
• Pre-funded warrants have an exercise price of $0.00001 per share and are exercisable immediately.
• Series A and B warrants have an exercise price of $0.20 per share.
• Series A warrants are exercisable after shareholder approval and expire in five years.
• Series B warrants are exercisable after shareholder approval and expire in two and a half years.
• The company intends to use the net proceeds to redeem outstanding Series B preferred stock and for general corporate purposes.
• The offering closed on January 16, 2025, with net proceeds of approximately $13.3 million.
• Potential additional gross proceeds from warrant exercises could reach $81.1 million.
• Company directors and officers have entered into 90-day lock-up agreements.
• The company has agreed not to issue further common stock or equivalents for 45 days after shareholder approval, subject to certain exceptions.

Sentiment

Score: 7

Explanation: The document indicates a successful capital raise, which is generally positive. However, the potential dilution from warrants and the restrictions on future issuances temper the overall sentiment.

Positives

• The company successfully raised $13.3 million in net proceeds.
• The offering provides potential for significant additional capital through warrant exercises.
• The company has secured funds to redeem outstanding Series B preferred stock.
• The company has a clear plan for the use of the net proceeds.

Negatives

• The company is subject to lock-up agreements for 90 days.
• The company is restricted from issuing further common stock or equivalents for 45 days after shareholder approval, subject to certain exceptions.
• The company is restricted from entering into variable rate transactions for 90 days after shareholder approval, subject to certain exceptions.
• There is no guarantee that the warrants will be exercised.

Risks

• The company's share price could be affected by the large number of warrants issued.
• The company's ability to raise additional capital may be limited by the lock-up agreements and restrictions on issuing new securities.
• The company's ability to achieve its business objectives depends on the successful use of the net proceeds.
• The company's share price could be affected by the need to obtain shareholder approval for the warrants.

Future Outlook

The company intends to use the net proceeds from the offering, together with existing cash, to redeem all outstanding shares of its Series B Preferred Stock and to build out product platforms, expand sales and marketing efforts, and for general corporate purposes. The company also plans to hold a shareholder meeting to obtain approval for the issuance of shares upon exercise of the warrants.

Industry Context

This announcement reflects a common strategy for small-cap companies to raise capital through public offerings, often including warrants to incentivize investment. The use of proceeds to pay down debt and fund growth is also typical.

Comparison to Industry Standards

• The structure of this offering, including the use of common stock, pre-funded warrants, and multiple series of warrants, is a relatively common approach for small-cap companies seeking to raise capital.
• The offering price of $0.10 per share is typical for companies at this stage of development.
• The inclusion of warrants with an exercise price of $0.20 is a common incentive for investors in such offerings.
• The lock-up agreements for directors and officers are standard practice to ensure stability after the offering.
• The use of an underwriter like Dawson James Securities is typical for companies of this size.
• The potential for additional capital through warrant exercises is a common feature of these types of offerings, but the actual amount raised is highly variable and dependent on market conditions and the company's performance.

Stakeholder Impact

• Shareholders may experience dilution if warrants are exercised.
• Employees may benefit from the company's increased financial stability.
• Customers may benefit from the company's expanded product platforms.
• Creditors may benefit from the company's improved financial position.

Next Steps

• The company will hold a shareholder meeting to obtain approval for the issuance of shares upon exercise of the warrants.
• The company will use the net proceeds to redeem outstanding Series B preferred stock and for general corporate purposes.
• The company will continue to operate under the terms of the lock-up agreements and restrictions on issuing new securities.

Key Dates

Keywords

public offering, common stock, warrants, pre-funded warrants, underwriting agreement, capital raise, lock-up agreement, shareholder approval, Dawson James Securities, Series A warrants, Series B warrants